EBIT at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's EBIT?
- Syndax Pharmaceuticals (SNDX) reported EBIT of -$34.2M in Q1 2026.
- How has Syndax Pharmaceuticals's EBIT changed year-over-year?
- Syndax Pharmaceuticals's EBIT increased by 59.2% year-over-year, from -$83.76M to -$34.2M.
- What is the long-term trend for Syndax Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's EBIT has grown at a 79.6% compound annual growth rate (CAGR), from $26.22M to -$273.08M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.